Release Date: 28/02/20 18:18 Summary: Preliminary Final Report Price Sensitive: Yes Download Document 423.48KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%